Previously treated cases tested for RR-/MDR-TB in Trinidad and Tobago
Trinidad and Tobago: Previously treated cases tested for RR-/MDR-TB was 27.0% in 2024. ◆ Volatile
Latest (2024)
27.0%
World rank
163rd
of 180 countries
All-time high
91.0%
in 2018
All-time low
0.0%
in 2009
Years of data
18
2005–2024
Previously treated cases tested for RR-/MDR-TB in Trinidad and Tobago, 2005–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Trinidad and Tobago recorded 27.0% for previously treated cases tested for rr-/mdr-tb in 2024.
The figure is down 6.9% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Trinidad and Tobago peaked at 91.0% in 2018 and was at its lowest, 0.0%, in 2009.
Trinidad and Tobago ranks 163rd of 180 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Previously treated cases tested for RR-/MDR-TB in Trinidad and Tobago, year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 14.0% | — |
| 2006 | 19.0% | +35.7% |
| 2007 | 77.0% | +305.3% |
| 2008 | 6.4% | -91.7% |
| 2009 | 0.0% | -100.0% |
| 2012 | 19.0% | — |
| 2013 | 46.0% | +142.1% |
| 2014 | 29.0% | -37.0% |
| 2015 | 32.0% | +10.3% |
| 2016 | 40.0% | +25.0% |
| 2017 | 40.0% | +0.0% |
| 2018 | 91.0% | +127.5% |
| 2019 | 61.0% | -33.0% |
| 2020 | 32.0% | -47.5% |
| 2021 | 59.0% | +84.4% |
| 2022 | 42.0% | -28.8% |
| 2023 | 0.0% | -100.0% |
| 2024 | 27.0% | — |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 23.3% | 0.0% | 77.0% | 5 |
| 2010s | 44.8% | 19.0% | 91.0% | 8 |
| 2020s | 32.0% | 0.0% | 59.0% | 5 |
Countries ranked near Trinidad and Tobago
- 160 Syrian Arab Republic 32.0% compare
- 161 Guinea 29.0% compare
- 161 North Macedonia 29.0% compare
- 164 Mozambique 25.0% compare
- 165 Cape Verde 20.0% compare
- 166 Djibouti 17.0% compare
More health data for Trinidad and Tobago
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.1463 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,638 deaths per 1,000 people (2090)
- Number of infants who die before age 1 24 deaths (2100)
- Population ages 40-44, male, annual growth rate 1.5 % change on previous year (2025)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, male, per capita 0.0446 units per person (2025)
- Population ages 45-49, female, annual growth rate 3.55 % change on previous year (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, female, per capita 0.0372 units per person (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Trinidad and Tobago?
- Previously treated cases tested for rr-/mdr-tb in Trinidad and Tobago was 27.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Trinidad and Tobago?
- The highest recorded value was 91.0% in 2018.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Trinidad and Tobago?
- The lowest recorded value was 0.0% in 2009.
- How does Trinidad and Tobago rank for previously treated cases tested for rr-/mdr-tb?
- Trinidad and Tobago ranks 163rd out of 180 countries with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Trinidad and Tobago?
- Over the last ten years it is down 6.9%. The long-run trend across the full record is volatile.
- Where does this Trinidad and Tobago data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).